| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | tobramycin (Bramitob®) |
| Formulation | 300 mg/4 ml nebuliser solution |
| Reference number | 54 |
| Indication | Management of chronic pulmonary infection due to pseudomonas aeruginosa in patients with cystic fibrosis aged 6 and older |
| Company | Chiesi Ltd |
| BNF chapter | Infections |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 04/08/2009 |